Evidence map›Paper›PMID 26339152›Full record

ArticleBioinformation2015

Modeling and structural analysis of human Guanine nucleotide-binding protein-like 3,nucleostemin.

Farinaz Nazmi, Mohammad Amin Moosavi, Marveh Rahmati, Mohammad Ali Hoessinpour-Feizi

Open access · hybridAbstract read
In one paragraph

Article in Bioinformation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Farinaz NazmiDepartment of Molecular Medicine, Institute of Medical biotechnology, National Institute for genetic Engineering and biotechnology, Tehran, Iran ; Department of Zoology, Faculty of Natural Science, The University of Tabriz, Iran.
Mohammad Amin MoosaviDepartment of Molecular Medicine, Institute of Medical biotechnology, National Institute for genetic Engineering and biotechnology, Tehran, Iran ; Hematology and Oncology Research Center, Tabriz University of medical Science, Tabriz, Iran.
Marveh RahmatiHematology and Oncology Research Center, Tabriz University of medical Science, Tabriz, Iran.
Mohammad Ali Hoessinpour-FeiziDepartment of Zoology, Faculty of Natural Science, The University of Tabriz, Iran.
National Institute of Genetic Engineering and Biotechnology · IRTabriz University of Medical Sciences · IRUniversity of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human GNL3 (nucleostemin) is a recently discovered nucleolar protein with pivotal functions in maintaining genomic integrity and determining cell fates of various normal and cancerous stem cells. Recent reports suggest that targeting this GTP-binding protein may have therapeutic value in cancer. Although, sequence analyzing revealed that nucleostemin (NS) comprises 5 permuted GTP-binding motifs, a crystal structure for this protein is missing at Protein Data Bank (PDB). Obviously, any attempt for predicting of NS structure can further our knowledge on its functional sites and subsequently designing molecular inhibitors. Herein, we used bioinformatics tools and could model 262 amino acids of NS (132-393 aa). Initial models were built by MODELLER, refined with Scwrl4 program, and validated with ProsA and Jcsc databases as well as PSVS software. Then, the best quality model was chosen for motif and domain analyzing by Pfam, PROSITE and PRINTS. The final model was visualized by vmd program. This predicted model may pave the way for next studies regarding ligand binding states and interaction sites as well as screening of databases for potential inhibitors.

Identifiers

PMID26339152
PMCPMC4546995
OpenAlexW1246699402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.